BCPS Study Guide 2026

Therapeutic decision-making in pharmacotherapy must prioritize clinical factors such as disease severity, comorbidities, and potential drug interactions. These must be combined with patient-specific considerations like age, renal/hepatic function, allergies, and individual preferences to ensure the chosen therapy is safe, effective, and tailored to the individual.

ASCO and NCCN guidelines recommend triple antiemetic therapy combining a 5-HT3 antagonist, NK1 receptor antagonist, and dexamethasone for highly emetogenic chemotherapy.

Regular safety drills ensure that all personnel are prepared to respond effectively during actual emergencies. Practice builds muscle memory, identifies gaps in emergency procedures, and improves overall response times.

When interpreting clinical study results, it is crucial to assess both statistical significance (whether the observed effect is likely due to chance) and clinical significance (whether the effect is meaningful and relevant to patient care). A statistically significant finding may not always be clinically important, and vice versa, making both essential for valid interpretation.

Fibrates are the drug of choice for severe hypertriglyceridemia because they activate PPAR-alpha, markedly reducing triglyceride synthesis and increasing HDL.

Oseltamivir (Tamiflu) inhibits viral neuraminidase, preventing release of new virions from infected cells, and is active against both influenza A and B.